H

Handshake Ventures

3 employees

Eminent Venture Capital is a private equity fund.

Investor insights

Sectors invested in

Biotechnology4

Health Care3

Medical Device2

Manufacturing2

Medical2

Therapeutics2

Health Diagnostics1

Gene Therapy1

Enzyme Therapy1

Autoimmune1

Biopharma1

Immunology1

Pharmaceutical1

Vascular Closure1

Interventional neurology1

Value-based Care1

interventional radiology1

Hospital Management1

Risk Sharing1

Vascular surgery1

Funding rounds participated in

$21M sweet spot round size

Most of their 6 investments are in rounds between $15M and $41M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Date founded

2017

Investments made

N

NEONC Technologies raised $10M on February 8, 2023

Investors: Orion BioScience, Li Family Office and Handshake Ventures

T

Tarveda Therapeutics raised $21M on January 7, 2015

Investors: Flagship Ventures, +ND Capital and Handshake Ventures

S

Selecta Biosciences raised $20M on October 15, 2014

Investors: JSC RUSNANO, +ND Capital, OrbiMed Advisors, Polaris Partners, I2BF Global Ventures, Flagship Ventures and Handshake Ventures

C

Cardiva Medical raised $16M on May 5, 2008

Investors: van Galen, AMKEY VENTURES LLC, PTV Healthcare Capital and Handshake Ventures

G

GlobeImmune, Inc. raised $41M on September 26, 2007

Investors: BNY Mellon, Washington Research Foundation, Richard King Mellon Foundation, Wexford Capital LP and Handshake Ventures

U

Undisclosed raised $45M on August 9, 2007

Investors: Gimv, Forward Ventures, YFY Biotech Management Company / Taiwan Global BioFund, InterWest Partners, Pacific Venture Group and Handshake Ventures